Shin Jin Young, Choi Yoon Ho, Song Yun Mi
a Department of Family Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea.
b Center for Supportive Care, Samsung Comprehensive Cancer Center, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea.
Nutr Cancer. 2015;67(7):1075-82. doi: 10.1080/01635581.2015.1073752. Epub 2015 Aug 28.
This cross-sectional study evaluated the risk of metabolic syndrome (MetS) in cancer survivors and family members. Subjects were 48,934 adults (24,786 men, 24,148 women) aged ≥40yr who receive a routine health examination at 1 hospital from January 2010 to December 2012. There were 2468 cancer survivors, 18,211 with cancer patients in the family, and 28,255 noncancer subjects, who never experienced cancer and whose family members either. Associations between MetS and cancer experience were assessed using multiple logistic regression analysis. The odds ratio (OR) of MetS in female cancer survivors was significantly higher than noncancer subjects after adjusting for age, smoking, physical activity, and alcohol intake (OR = 1.22, 95% confidence intervals: 1.02-1.47]. However, the OR of MetS for male survivors did not differ from that of noncancer subjects. Gastric cancer survivors had a lower OR of MetS than noncancer subjects (0.37, 0.27-0.50). ORs of breast cancer (1.49, 1.00-2.23) and prostate cancer survivors (1.46, 1.07-1.99) were higher than the OR of MetS for noncancer subjects. There was no difference in the OR of MetS between the family members of cancer patients and non-cancer subjects. These findings suggest that the odds of MetS for cancer survivors may differ by cancer type and by sex.
这项横断面研究评估了癌症幸存者及其家庭成员患代谢综合征(MetS)的风险。研究对象为2010年1月至2012年12月期间在1家医院接受常规健康检查的48934名年龄≥40岁的成年人(24786名男性,24148名女性)。其中有2468名癌症幸存者,18211名家庭成员中有癌症患者,以及28255名非癌症受试者,他们本人从未患过癌症且其家庭成员也没有。使用多因素逻辑回归分析评估MetS与癌症经历之间的关联。在调整年龄、吸烟、身体活动和酒精摄入量后,女性癌症幸存者患MetS的比值比(OR)显著高于非癌症受试者(OR = 1.22,95%置信区间:1.02 - 1.47)。然而,男性幸存者患MetS的OR与非癌症受试者并无差异。胃癌幸存者患MetS的OR低于非癌症受试者(0.37,0.27 - 0.50)。乳腺癌(1.49,1.00 - 2.23)和前列腺癌幸存者(1.46,1.07 - 1.99)患MetS的OR高于非癌症受试者。癌症患者的家庭成员与非癌症受试者患MetS的OR没有差异。这些发现表明,癌症幸存者患MetS的几率可能因癌症类型和性别而异。